SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $130,000 | -19.3% | 37,897 | +95.7% | 0.00% | – |
Q4 2021 | $161,000 | -52.9% | 19,363 | +34.9% | 0.00% | -100.0% |
Q2 2021 | $342,000 | -88.3% | 14,358 | -89.9% | 0.00% | -94.1% |
Q1 2021 | $2,932,000 | -15.6% | 142,382 | +0.5% | 0.02% | -34.6% |
Q4 2020 | $3,472,000 | +12.0% | 141,712 | +29.4% | 0.03% | -38.1% |
Q3 2020 | $3,101,000 | +448.8% | 109,540 | -7.7% | 0.04% | +366.7% |
Q2 2020 | $565,000 | +195.8% | 118,614 | +121.2% | 0.01% | +80.0% |
Q1 2020 | $191,000 | -79.6% | 53,633 | -80.2% | 0.01% | -16.7% |
Q4 2019 | $936,000 | +335.3% | 271,287 | +407.1% | 0.01% | +200.0% |
Q3 2019 | $215,000 | +82.2% | 53,500 | +291.1% | 0.00% | 0.0% |
Q2 2018 | $118,000 | – | 13,681 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
Geduld E E | 15,000 | $149,000 | 0.08% |
Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |